Products Firocoxib is commercially available as chewable tablets for dogs and as a paste for administration in horses. It has been approved in many countries since 2004. Structure and properties Firocoxib (C17H20O5S, Mr = 336.4 g/mol) is a furanone derivative. Like other COX-2 inhibitors, it has a V-shaped structure that allows binding to the Active … Firocoxib
Products Cimicoxib is commercially available in the form of chewable tablets for dogs (Cimalgex). It has been approved in many countries since 2011. Structure and properties Cimicoxib (C16H13ClFN3O3S, Mr = 381.8 g/mol) is a chlorinated and fluorinated benzenesulfonamide and imidazole derivative. It has a V-shaped structure like other COX-2 inhibitors, which allows binding to the … Cimicoxib
Products Mavacoxib is commercially available in the form of chewable tablets for dogs (Trocoxil). It has been approved in many countries since 2009. Structure and properties Mavacoxib (C16H11F4N3O2S, Mr = 385.3 g/mol) is a pyrazole benzenesulfonamide that exists as a white to off-white powder. It is nearly insoluble in water at a pH between 1.2 … Mavacoxib
Products Robenacoxib is commercially available in tablet form and as a solution for injection for dogs and cats (Onsior). It has been approved in many countries since 2009. Structure and properties Robenacoxib (C16H13F4NO2, Mr = 327.3 g/mol) is structurally related to diclofenac. Effects Robenacoxib (ATCvet QM01AH91) has analgesic and anti-inflammatory properties. The effects are due … Robenacoxib
